Development of radiopharmaceuticals for molecular imaging

International Congress Series

Volumn 1264, Issue C, 2004, Pages 139-147

  Saji, Hideo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Drug design; Molecular imaging; Radiolabeled antisense oligodeoxynuclide; Radiolabeled receptor binding ligand; Radiolabeled reporter probes

Indexed keywords

EID: 36849006231     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2003.12.076     Document Type: Article

References (19)

1. Phelps, M.E., PET: the merging of biology and imaging into molecular imaging. J. Nucl. Med. 41 (2000), 661–681.
2. Weissleder, R., Mahmood, U., Molecular imaging. Radiology 219 (2001), 316–333.
3. Blasberg, R., PET imaging of gene expression. Eur. J. Cancer 38 (2002), 2137–2146.
4. Blasberg, R., Tjuvajev, J.G., In vivo molecular-genetic imaging. J. Cell Biochem. Suppl. 39 (2002), 172–183.
5. Blasberg, R., Imaging gene expression and endogenous molecular imaging. J. Cereb. Blood Flow Metab. 22 (2002), 1157–1164.
6. Jacobs, A.H., Li, H., Winkeler, A., Hilker, R., Knoess, C., Ruger, A., Galldiks, N., Schaller, B., Sobesky, J., Kracht, L., Monfared, P., Klein, M., Vollmar, S., Bauer, B., Wagner, R., Graf, K., Wienhard, K., Herholz, W.D., PET-based molecular imaging in neuroscience. Eur. J. Nucl. Med. Mol. Imaging 30 (2003), 1051–1065.
7. Hnatowich, D.J., Antisense and nuclear medicine. J. Nucl. Med. 40 (1999), 693–703.
8. Fujita, M., Innis, R.B., In vivo molecular imaging: ligand development and research applications. Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C., (eds.) Neuropsychopharmacology: The Fifth Generation of Progress, 2002, Lippincott, Williams and Wilkins, Philadelphia, 411–425.
9. Talbot, P.S., Laruelle, M., The raole of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development. Eur. Neuropsychopharmacol. 12 (2002), 503–511.
10. Paterson, D., Nordberg, A., Neuronal nicotic receptors in the human brain. Prog. Neurobiol. 61 (2000), 75–111.
11. 11C]nicotine and its regional distribution in the mouse brain: a potential tracer for visualization of brain nicotinic receptors by positron emission tomography. Chem. Pharm. Bull. 40 (1992), 734–736.
12. 123I](S)-5-iodonicotine, a new radioiodinated ligand, in the assay of nicotinic acetylcholine receptor binding in the brain. Biol. Pharm. Bull. 18 (1995), 1463–1466.
13. Saji, H., Watanabe, A., Magata, Y., Ohmomo, Y., Kiyono, Y., Yamada, Y., Iida, Y., Yonekura, Y., Konishi, J., Yokoyama, A., Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography. Chem. Pharm. Bull. 45 (1997), 284–290.
14. Saji, H., Ogawa, M., Ueda, M., Iida, Y., Magata, Y., Tominaga, A., Kawashima, H., Kitamura, Y., Nakagawa, M., Kiyono, Y., Mukai, T., Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors. Ann. Nucl. Med. 16 (2002), 189–200.
15. Saji, H., Targeted delivery of radiolabeled imaging and therapeutic agents: bifunctional radiopharmaceuticals. Crit. Rev. Ther. Drug Carr. Syst. 16 (1999), 209–244.
16. Mukai, T., Hanaoka, H., Tamamura, H., Mori, T., Ishino, S., Doi, R., Fujii, N., Saji, H., Synthesis and evaluation of indium-111-labeled peptide derivative targeted to a chemokine receptor CXCR4. J. Label. Compd. Radiopharm., 46, 2003, S304.
17. Gambhir, S.S., Barrio, J.R., Herschman, H.R., Phelps, M.E., Assays for noninvasive imaging of reporter gene expression. Nucl. Med. Biol. 26 (1999), 481–490.
18. MacLaren, D.C., Gambhir, S.S., Satyamurthy, N., Barrio, J.R., Sharstein, S., Toyokumi, T., Wu, L., Berk, A.J., Cherry, S.R., Phelps, M.E., Herschman, H.R., Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6 (1999), 785–791.
19. Chung, J.K., Sodium iodide symporter: its role in nuclear medicine. J. Nucl. Med. 43 (2002), 1188–1200.